Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
Great post and valuation rationale. ALL adds up to a fantastic opportunity. Anyone who doesn't understand that the fundemental reasons for buying into this are stronger today after yesterday. Will fill up the tank if this heads lower.
Good post and agree it's a great opportunity made
more high profile by yesterdays shenanigans. Any drops will be bought (if I get the chance I will) so expecting this to hold and move up towards the end of the day. No RNS today re DF or yesterday will look even more dodgy.
If another Covid stock release big news this may head lower imo as the swarm bumble off for the day.
No reason or justification for a placing.
Income set to grow, funding for test development from HMG.
Still holding ODX and AVCT and will continue to do so with all patient humility for the potential opportunity both shares offer.
ODX still have the governments backing through consortium. Still has a LFD test due for release. Just advertised for 20 new technical roles for 24/7 production and 5 additional chemists to increase productivity...still have stated they are increasing production capacity up to 50m pa.
Shocker of an RNS at 1534 today but there was no material disclosure in this mornings interview, should have told the Nomad to jog on, didn't need to clarify anything other than to say he was bullish in the Sky TV interview.
That said no impact on existing holders other than an 18% jump. Rainbow chasers got caught when jumping onboard a 50% rise without real news.
I learnt from this and will let the story play out for the RNS, hopefully a more consolidated rise will be the result before I exit ODX.
More rumours re news. Also recruitment for production ramping up for 24 hour shift work for Covid related co in Stirling....
https://twitter.com/Belcourtoi/status/1265518862910533632?s=19
Great find and a good clue as to what's coming and it seems v soon.
Thread is good re rational for no comms from ODX. The job ad checks out also.
Both are working on LFD and other projects.
ODX will tell you have I had Covid?
AVCT have I got Covid?
ODX also have a manufacturing agreement with Molotic and ar part of the governments response consortium. They also have LFD for HIV.
AVCT have a fast throughput mass spectrometry test for hospitals, a potential therapeutic for covid, cancer therapeutics, the Direct to consumer deal with medusa 19.
Lots up upside for both BUT equally both are pending confirmation of success re tests and regulatory approval.
I hold both.
I hold from 55p in TILS and agree there is some exciting, novel and peer reviewed research in Stemprinter. My plan was to add more in about a month but Friday's news was a great surprise so I topped up by selling some ODX. I'm not selling any AVCT. Some great posts and the CEO interview on TILS BB.
Mmm so possibly equity issue then.
or partner investor, either way they need the capital to get the Stemprinter to next stage.
I'm hoping they get the project further along before a buy out....for obvious value reasons. I only hold small here but will top up if I can sun £1
Great news re like for like equity in new Stemprinter TILS.
How do you think the new co will be funded in its development. Will they take cash out of TILS or do you think the will issue more shares? I know the CEO said 100% though.....?
Yep agree re complicated and long process but Covid I feel every older person likely to want to risk a vaccine. They will/are getting this news out there so perhaps that will impact on SP until we hear more re Cytiva and ultimately FDA approval. Timeline of Sept does concern me though.
https://www.***************************/astrazeneca-concludes-first-agreements-for-university-of-oxfords-potential-covid-19-new-vaccine/412823632?amp&__twitter_impression=true
I note a link to AZN RNS was put up on the BB here earlier but not picked up for discussion.
Would appreciate a bit of sentiment/perspective on this, likely hood and impact.
Seems very fast re September manufacturing, every other vaccine ever has needed 5 years lab to green light.
I note they do say it may not work, but going to stage 3 of trial globally shortly etc What's the sentiment re impact on testing/diagnostics sector. Likely to reduce commercial horizon I would of thought.
I hold AVCT and ODX not AZN!